Leukemia


Venclexta® and Low-doses of Cytarabine Effective in Elderly with Acute Myeloid Leukemia (01-26-2017)

The treatment combination consisting of Venclexta® (venetoclax) plus low-doses of the chemotherapy agent cytarabine appears to be an effective and tolerable treatment regimen for elderly patients with acute myeloid leukemia (AML) who are not eligible... Continue Reading

Blincyto® (05-19-2015)

Class: Biological Therapy Generic Name: blinatumomab Trade Name: Blincyto® For which conditions is this drug approved? Blincyto® is approved for treatment of a certain type of acute lymphoblastic leukemia (ALL): Philadelphia chromosome-negative relapsed... Continue Reading

blinatumomab (05-19-2015)

Class: Biological Therapy Generic Name: blinatumomab Trade Name: Blincyto® For which conditions is this drug approved? Blincyto® is approved for treatment of a certain type of acute lymphoblastic leukemia (ALL): Philadelphia chromosome-negative relapsed... Continue Reading

CML Patients Treated with Gleevec Have Normal Life Expectancy (03-31-2011)

People with chronic myeloid leukemia (CML) that is in complete remission after two years of treatment with Gleevec® (imatinib) have survival rates that are similar to those of the general population. These results were published in the Journal of the... Continue Reading

Life’s Lessons Learned Early (03-20-2009)

By Diana Price When Pia Awal went to the emergency room in June 2002 after suffering from a fever that antibiotics couldn’t wipe out and bone pain that was getting increasingly worse, the last thing she expected to hear was a cancer diagnosis. And when... Continue Reading

Cancer’s Glamour Girl (03-20-2009)

Down-to-earth and down-to-business when it comes to cancer advocacy, Erin Zammett Ruddy discusses her very public journey with chronic myeloid leukemia and why she continues to share her story. by Diana Price Erin Zammett Ruddy always wanted to be famous—at... Continue Reading

Leukemia Overview (03-19-2009)

Overview Leukemia is a cancer of the blood cells. There are many different types of leukemia, depending upon which specific blood cells are affected. Each leukemia has different disease characteristics and therefore different treatment options. Several... Continue Reading

Treanda® and Rituxan® Effective for Relapsed CLL (12-11-2008)

Treanda® and Rituxan® Effective for Relapsed CLL In a Phase II clinical trial, the combination of Treanda® (bendamustine)®and Rituxan® (rituximab)®produced promising results among patients with relapsed chronic lymphocytic leukemia (CLL). These... Continue Reading

Relapsed or Refractory Adult ALL (10-6-2008)

Overview Patients with progressive or relapsed adult ALL remain curable despite failing initial treatment. Patients failing treatment can be divided into two broad categories. Patients who fail to achieve an initial complete disappearance or remission... Continue Reading

Adult Acute Lymphoblastic Leukemia: Post-Remission Treatment (10-1-2008)

Overview If a complete remission is achieved following remission induction therapy and no further treatment given, over 90% of patients will have a recurrence of leukemia in weeks to months. However, treatment with standard intensive post-remission therapy... Continue Reading

« Previous PageNext Page »